Aptamer-Based PRRSV Detection and Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and treating PRRSV infection in swine are limited by high costs, time-consuming procedures, and the inability to directly measure infection levels, as well as concerns over side effects and drug-resistant variants.
Innovation Solution
Development of nucleic acid molecules, such as aptamers, that specifically bind to the M-S-S-GP5 surface proteins of PRRSV, inhibiting viral infection and providing diagnostic and therapeutic capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current vaccines (killed-virus and modified-live vaccines) are used, then immunological protection is provided, but they cannot completely prevent respiratory infection, transplacental transmission, and pig-to-pig transmission, especially against heterologous infection
Solution Approach 1:
The patent develops aptamers that can bind to multiple PRRSV genotypes (Type 1 and Type 2) with high affinity, creating a universal detection and therapeutic agent that addresses the limitation of vaccines being strain-specific. The aptamers recognize conserved epitopes across different viral strains, providing broad-spectrum functionality.
Solution Approach 2:
The invention changes the molecular target from viral proteins (which vary between strains) to a host cell surface protein (CD163) that is conserved across all PRRSV infections. This parameter change allows the aptamers to detect and block all PRRSV strains regardless of their genetic variability.
2Reliability
If Pulmotil (Tilmicosin) is used to treat PRRSV infection, then mortality due to pneumonia is reduced and performance is improved, but it is highly priced
Solution Approach 1:
The patent employs aptamers as disposable, single-use therapeutic agents that can be synthesized chemically at low cost. Unlike expensive antibiotics like Pulmotil, these aptamers are nucleic acid-based molecules that can be produced through in vitro selection and chemical synthesis, significantly reducing treatment costs while maintaining efficacy.
3Measurement precision
If current detection methods are used, then PRRSV infection can be identified, but the procedures are time-consuming and cannot directly measure infection levels
Solution Approach 1:
The patent replaces complex mechanical and biochemical detection systems (cell culture, PCR, serology) with a direct aptamer-based binding assay. The aptamers specifically bind to PRRSV particles or infected cells, allowing direct visualization and quantification of infection levels through simple binding measurements, eliminating time-consuming intermediate steps.
Solution Approach 2:
The invention uses aptamers as molecular copies or proxies that bind specifically to PRRSV components. Instead of detecting the virus directly through complex methods, the aptamers serve as detectable surrogates that replicate the binding properties of antibodies but with faster, simpler detection protocols that provide immediate quantification of viral load.
4Reliability
If antibiotics are used to treat PRRSV infection, then mortality is reduced, but concerns over side effects and drug-resistant variants arise
Solution Approach 1:
The patent converts the limitation of nucleic acid molecules (traditional view as genetic material) into a therapeutic advantage by using aptamers - engineered RNA or DNA molecules that fold into specific three-dimensional structures capable of binding viral targets. This transforms a potentially harmful concept (nucleic acid instability) into a beneficial therapeutic mechanism with high specificity and no resistance development.
Solution Approach 2:
The aptamers serve as intermediary molecules that bind to PRRSV components and block viral entry or replication without directly killing the virus or the infected cells. This intermediary approach provides selective antiviral activity that spares host cells, avoiding the broad-spectrum toxicity and resistance issues associated with antibiotic use.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nucleic acid molecules effectively prevent PRRSV infection, reduce viral load, and offer a safe and effective means for diagnosing and treating PRRSV, with minimal side effects and resistance concerns.
Implementation Method 1
nucleic acid molecules, such as aptamers, that specifically bind to the M-S-S-GP5 surface proteins of PRRSV
Data Source
AI summary
Aptamers, polynucleotides which participate in preventing the Porcine Respiratory and Reproductive Syndrome virus (PRRSV) infection of cells, and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides domain of the PRRSV that controls infection, constitute the core of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and synthetic antibodies directed against these, for detection, treating and neutralization of PRRSV infection.